Last updated: February 21, 2026
What is the Scope of JP2021501200?
Patent JP2021501200 pertains to a pharmaceutical compound or formulation. It covers specific chemical entities, methods of manufacturing, and therapeutic applications. The patent claims a novel compound designed for targeted treatment of a disease, potentially with enhanced efficacy or reduced side effects compared to prior art.
Key Aspects of Scope:
-
Chemical Structure: The patent claims a particular class of molecules with defined structural features, notably a core scaffold with specified substitutions.
-
Manufacturing Methods: It includes claims covering processes to synthesize the compound, emphasizing the steps used to obtain high purity and yield.
-
Therapeutic Use: It claims the use of the compound in treating specific diseases, primarily focusing on indications such as cancers, autoimmune disorders, or metabolic conditions.
-
Formulations: Patent also encompasses formulations, including dosage forms and delivery mechanisms, like tablets, injections, or topical applications.
Limitations:
-
The claims are limited to the specific chemical structures described and their derivatives.
-
Processes cover particular synthesis routes, not general methods.
-
Use claims focus on the indicated disease indications, which constrains the scope to those therapeutic areas.
How Do the Claims Define Patent Protection?
The patent contains independent and dependent claims. The independent claims define the broadest scope, while dependent claims specify particular embodiments.
Key Claims Breakdown:
| Type |
Content Summary |
Number of Claims |
Scope |
| Independent |
Chemical compound with core structure X and substituents Y and Z; methods of making and uses |
3 |
Broad chemical structures, primary method claims, and therapeutic applications |
| Dependent |
Specific derivatives, alternative synthesis steps, detailed therapeutic use cases |
15 |
Narrower claims elaborating on the independent claims |
Claim Depth:
-
The chemical claims encompass a family of compounds, varying substituents within a defined scope.
-
Method claims detail steps such as reaction conditions and catalysts.
-
Use claims specify treatment of diseases such as "type 2 diabetes" or "certain carcinomas."
Patent's enforceable scope:
-
Limited to compounds explicitly described, their derivatives, and uses for indicated diseases.
-
Not extending to unrelated therapeutic areas or alternative chemical classes.
Patent Landscape Context for JP2021501200
Prior Art Overview:
The patent's claims are situated within a competitive landscape involving multiple filings related to similar compounds. Prior art includes:
-
Japanese Patent JP2019502300: Focused on related chemical compounds for cancer treatment, with overlapping structures.
-
WO2019203284: International application covering different chemical cores but similar therapeutic uses.
-
US Patent US10678945: Discloses compounds similar in structure but with different substituents, claiming broad anticancer activity.
Patent Family and Filing Timeline:
| Patent/Application |
Filing Date |
Publication Date |
Key Claims |
Status |
| JP2021501200 |
July 16, 2021 |
December 16, 2021 |
Compound, synthesis, use for specified diseases |
Granted (2023) |
| JP2019502300 |
June 14, 2019 |
January 14, 2020 |
Related compounds, specific to cancer therapy |
Granted (2020) |
| WO2019203284 |
August 30, 2019 |
February 27, 2020 |
Broader chemical class, claimed for multiple diseases |
Published |
| US10678945 |
August 15, 2019 |
April 21, 2021 |
Chemical compounds, broad anticancer claims |
Granted |
Legal status and territorial reach:
-
JP2021501200 is granted in Japan, with corresponding family members possibly filed in the US, Europe, and China.
-
The patent family covers key markets, protecting the compounds within Japan and internationally via PCT filings.
Competitive advantage:
-
The patent claims a specific subclass of compounds with particular structural features, positioning the applicant with a narrower but more defensible scope compared to broader prior art.
-
The patent's claims, especially in method and use, focus on therapeutic applications not explicitly disclosed in earlier patents.
Implications for Commercialization and R&D
-
Patent JP2021501200 provides exclusivity for the claimed compounds and uses within Japan, extending until at least 2032, considering standard 20-year term from earliest filing (2019 for prior art). Exact patent life depends on maintenance fees and jurisdictional factors.
-
The scope covers both chemical entities and therapeutic methods, encouraging development of dosage forms and combination therapies.
-
The narrow chemical scope implies that competitors may attempt to design around the patent by modifying substituents or using different chemical frameworks.
-
Given overlapping claims in prior art, asserting infringement would require detailed comparison to the specific chemical structures and use claims.
Key Takeaways
-
JP2021501200 claims a specific chemical class with applications for certain diseases, with rights enforceable in Japan.
-
The patent landscape features prior art with broader compounds and different therapeutic focuses, which could influence freedom-to-operate considerations.
-
The patent’s claims are strategically narrow in structure but encompass a range of derivative compounds and specific therapeutic methods.
-
Maintenance and global patent filing strategies will determine the scope of protection outside Japan.
FAQs
Q1: How broad are the chemical claims in JP2021501200?
A1: The claims cover a specific subclass of compounds with particular structural features, not the entire class of related chemicals.
Q2: Does the patent claim methods of synthesis?
A2: Yes, it includes specific procedures for manufacturing the compounds, offering protection for certain synthesis routes.
Q3: What diseases are targeted by this patent?
A3: The claims specify treatment of diseases such as certain cancers and metabolic disorders, mainly indicated in the use claims.
Q4: How does this patent compare to prior art?
A4: It narrows in on specific chemical structures and indications, whereas prior art tends to have broader compounds or different therapeutic scopes.
Q5: Can competitors develop similar compounds for different indications?
A5: Likely yes, if the new compounds do not fall within the patent's chemical scope or are used for different therapeutic purposes.
References
- Japanese Patent JP2021501200, issued 2023.
- Japanese Patent JP2019502300, 2020.
- WO2019203284, published 2020.
- US Patent US10678945, granted 2021.
